Short Interest in Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Grows By 797.8%

Key Points

• Short interest surged 797.8% to 34,223 shares as of August 31, up from 3,812 shares on August 15. Despite the increase, short interest represents 0.0% of shares outstanding, with a 0.3-day days-to-cover ratio.
• Analyst sentiment is broadly positive: Goldman Sachs and Jefferies upgraded the ADR to “strong buy,” while Zacks Research moved it from “strong sell” to “hold.” The stock has an overall average rating of “Buy.”
• Shionogi reported quarterly EPS of $0.36, beating the $0.18 consensus estimate, while revenue of $1.04 billion exceeded expectations of $970.69 million. Shares recently traded at $9.04, within a 52-week range of $7.65 to $12.00.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 34,223 shares, a growth of 797.8% from the August 15th total of 3,812 shares. Based on an average daily trading volume, of 114,861 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.0% of the company's shares are short sold.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on SGIOY. The Goldman Sachs Group upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong-buy" rating in a report on Monday, June 15th. Jefferies Financial Group raised Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 14th. Finally, Zacks Research upgraded Shionogi & Co., Ltd. Unsponsored ADR from a "strong sell" rating to a "hold" rating in a research report on Monday, May 25th. Two investment analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Buy".

Shionogi & Co., Ltd. Unsponsored ADR Stock Up 0.2%

SGIOY stock traded up $0.02 during mid-day trading on Thursday, reaching $9.04. The company had a trading volume of 202,000 shares, compared to its average volume of 81,849. Shionogi & Co., Ltd. Unsponsored ADR has a 52 week low of $7.65 and a 52 week high of $12.00. The company has a market capitalization of $15.39 billion, a price-to-earnings ratio of 9.04, a PEG ratio of 3.23 and a beta of 0.08. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.14 and a quick ratio of 1.46. The stock has a 50 day simple moving average of $8.96 and a two-hundred day simple moving average of $9.60.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.18. The company had revenue of $1.04 billion during the quarter, compared to analysts' expectations of $970.69 million. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 16.13% and a net margin of 46.67%. As a group, equities analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.82 earnings per share for the current fiscal year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines. Founded in Osaka in 1878, the company has built its business around drug discovery and has a particular focus on infectious diseases, including antiviral and antibacterial treatments.

Shionogi's products include Xofluza (baloxavir marboxil), an oral treatment for influenza, and Fetcroja (cefiderocol), an antibiotic used for certain difficult-to-treat bacterial infections.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.